Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-Risk Prostate Cancer”

719 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 719 results

Not applicableUnknownNCT05430737
What this trial is testing

A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer

Who this might be right for
Prostate CancerStereotactic Body RadiotherapyHigh-risk+2 more
West China Hospital 60
Very early researchStudy completedNCT04301414
What this trial is testing

Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Columbia University 26
Early research (Phase 1)Study completedNCT02064036
What this trial is testing

Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate

Who this might be right for
Adenocarcinoma of the Prostate
University of California, Davis 17
Not applicableEnded earlyNCT04234399
What this trial is testing

Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomy

Who this might be right for
Prostatic Neoplasm
University of Vermont 22
Testing effectiveness (Phase 2)Study completedNCT01946165
What this trial is testing

Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 69
Large-scale testing (Phase 3)UnknownNCT00003734
What this trial is testing

Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
St. Luke's Hospital, Ireland 276
Not applicableStudy completedNCT01535898
What this trial is testing

Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate Cancers

Who this might be right for
Head and Neck CancerProstate Cancer
Memorial Sloan Kettering Cancer Center 10
Not applicableUnknownNCT03838432
What this trial is testing

The Composite Steep-pulse Treatment Apparatus Used in Prostate Cancer Ablation Therapy

Who this might be right for
Prostate Cancer
Second Military Medical University 119
Not applicableActive Not RecruitingNCT01653093
What this trial is testing

3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer

Who this might be right for
Prostate Cancer
University of Cincinnati 280
Not applicableUnknownNCT00392535
What this trial is testing

Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Institute of Cancer Research, United Kingdom 3,216
Testing effectiveness (Phase 2)Study completedNCT02967458
What this trial is testing

Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study

Who this might be right for
Prostatic Neoplasm
Thomas Jefferson University 55
Not applicableStudy completedNCT01664130
What this trial is testing

High-Dose Stereotactic Radiation for Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
Case Comprehensive Cancer Center 35
Testing effectiveness (Phase 2)WithdrawnNCT03035357
What this trial is testing

Neoadjuvant Listeria or Daratumumab in Prostate Cancer

Who this might be right for
Malignant Neoplasms of Male Genital OrgansProstate Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00924807
What this trial is testing

Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
Beth Israel Medical Center 4
Not applicableStudy completedNCT02618161
What this trial is testing

Timing of HDR With EBRT in Localised Prostate Cancer,Toxicity and Quality of Life Assessment

Who this might be right for
Prostate Cancer
Mid and South Essex NHS Foundation Trust 100
Not applicableStudy completedNCT00535977
What this trial is testing

Broccoli, Peas and PIN

Who this might be right for
Prostatic Intraepithelial Neoplasia
Quadram Institute Bioscience 22
Post-approval studies (Phase 4)Active Not RecruitingNCT06627530
What this trial is testing

COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcer

Who this might be right for
Prostate Cancer
Brazilian Clinical Research Institute 144
Very early researchLooking for participantsNCT06888102
What this trial is testing

A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer

Who this might be right for
High-risk Prostate Cancer
Edwin Posadas, MD 20
Testing effectiveness (Phase 2)Study completedNCT01250717
What this trial is testing

Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Beth Israel Deaconess Medical Center 28
Not applicableWithdrawnNCT00621413
What this trial is testing

Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
IsoRay Medical, Inc.
Load More Results